Skip to main content

Remote Job Finders (RJF)

Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location

Following the withdrawal of billions of dollars in investments from Boehringer Ingelheim and Eli Lilly, German lawmakers have proposed a clause to the country’s healthcare reforms set to take effect Jan. 1.

US explores China biotech restrictions, exempts licensing deals

A new proposal from the U.S. government seeking to address investment in Chinese biotech as a matter of national security drew cautious statements from across the industry, with leaders vowing to ensure innovation isn’t stifled.
Scroll to top